Joseph J. Manning - Sep 8, 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Joseph J. Manning by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Sep 8, 2022
Transactions value $
-$1,440,301
Form type
4
Date filed
9/9/2022, 05:27 PM
Previous filing
Aug 26, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $1.02M +23K +43.21% $44.40 76.3K Sep 8, 2022 Direct
transaction ABT Common shares without par value Sale -$2.46M -23K -30.17% $107.00 53.2K Sep 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -23K -100% $0.00* 0 Sep 8, 2022 Common Shares 23K $44.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).